Targeted systemic therapies for hepatocellular carcinoma: Clinical perspectives, challenges and implications

doi:10.3748/wjg.v18.i6.498

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6140)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-2) series.

Item

Count

PDF

489

HTML

5144

Tables (1-2)

507

Sum=6140

Feb 14, 2012 (publication date) through Oct 30, 2025

Times Cited of This Article

Times Cited (40)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Review

World J Gastroenterol. Feb 14, 2012; 18(6): 498-506
Published online Feb 14, 2012. doi: 10.3748/wjg.v18.i6.498

Targeted systemic therapies for hepatocellular carcinoma: Clinical perspectives, challenges and implications

Catherine Frenette, Robert Gish

Catherine Frenette, Robert Gish, California Pacific Medical Center, San Francisco, CA 94115, United States

Author contributions: Frenette C and Gish R contributed equally to the writing of this manuscript.

Correspondence to: Catherine Frenette, MD, Medical Director of Liver Transplantation, Director of Liver Cancer Program, The Methodist Hospital, Houston, TX 77030, United States. ctfrenette@tmhs.org

Telephone: +1-713-4410179 Fax: +1-731-4415248

Received: February 21, 2011
Revised: June 6, 2011
Accepted: June 13, 2011
Published online: February 14, 2012

Core Tip